Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 19, 2025
American Kidney Fund’s Kidney Health for All™ Health Equity Media Campaign Expands to More Communities Nationwide
GlobeNewswire
·
May 19, 2025
ROCKVILLE, Md., May 19, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has launched the next phase of its national Kidney Health for All™ media campaign, connecting millions more people with resources to help prevent kidney disease in high-risk …
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
GlobeNewswire
·
May 19, 2025
HENDERSON, Nev., May 19, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) presents projected revenue for each market with exclusive distribution agreement. NIKA has previously reported an estimated potential €7.9 billion in revenue from …
Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida
GlobeNewswire
·
May 19, 2025
OCALA, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- Residents of North Central Florida now have easier access to high-quality, compassionate hospice services from the nation’s leading provider of end-of-life care. On May 15, VITAS Healthcare began accepting …
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
GlobeNewswire
·
May 19, 2025
Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer Steven will lead the regulatory and development …
Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes
GlobeNewswire
·
May 19, 2025
DENVER, May 19, 2025 (GLOBE NEWSWIRE) -- Porch Light Health (PLH) has partnered with CHESS Health to use its innovative, automated Contingency Management Rewards Engine in the treatment of individuals with substance use disorder (SUD) across thirteen of …
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
GlobeNewswire
·
May 19, 2025
HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced the appointment of Michael Tung, M.D., MBA as Executive Vice President and Chief Financial Officer, effective …
Living with disability? You are invited to Joni and Friends Family Retreat
GlobeNewswire
·
May 19, 2025
Ridgeland, Mississippi, May 19, 2025 (GLOBE NEWSWIRE) -- Did you know that families with disability can find community and respite this summer? Joni and Friends, an international disability ministry with an office in Ridgeland, is actively …
Living with disability? Registration is open for no-cost Summer Adventure program
GlobeNewswire
·
May 19, 2025
East St. Louis, Illinois, May 19, 2025 (GLOBE NEWSWIRE) -- For many families, summer means scrambling to find caregiving arrangements. For families living with disability, the search for summer help is even harder. Thankfully, the disability ministry …
Thousands of Retailers Across the Country Partner with Muscular Dystrophy Association to Send Kids to Summer Camp at No Cost to Families
GlobeNewswire
·
May 19, 2025
New York, May 19, 2025 (GLOBE NEWSWIRE) -- This summer, shoppers across the U.S. have the chance to make an extraordinary difference in the lives of kids and young adults living with neuromuscular diseases, by participating in the pinup and roundup …
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
GlobeNewswire
·
May 19, 2025
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed results from Phase 1 later in 2025 following completion of …
Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer
GlobeNewswire
·
May 19, 2025
CAMBRIDGE, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Don Haut, Ph.D., as Chief Business Officer. In …
MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results
GlobeNewswire
·
May 19, 2025
TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results …
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
GlobeNewswire
·
May 19, 2025
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND and/or CTA for Wilson’s Disease and AATD programs in 1H 2026 …
Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy
GlobeNewswire
·
May 19, 2025
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the …
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
GlobeNewswire
·
May 19, 2025
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels …
Lifeward Names Mark Grant as New CEO
GlobeNewswire
·
May 19, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a …
Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161
GlobeNewswire
·
May 19, 2025
JUV-161 is a first-in-class muscle regenerating biologic that will address myopathies starting with Myotonic Dystrophy Type 1 JUV-161 was discovered using Juvena’s proprietary JuvNET platform, an AI and stem cell secretome-based drug discovery and …
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE
GlobeNewswire
·
May 19, 2025
WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, is expanding its …
SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.
GlobeNewswire
·
May 19, 2025
TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, …